Martin Gabriel
Gabriel, Martin 1974-
VIAF ID: 12765571 (Personal)
Permalink: http://viaf.org/viaf/12765571
Preferred Forms
- 100 1 _ ‡a Gabriel, Martin ‡d 1974-
- 100 1 _ ‡a Gabriel, Martin ‡d 1974-
- 100 0 _ ‡a Martin Gabriel
4xx's: Alternate Name Forms (3)
5xx's: Related Names (1)
- 551 _ _ ‡a München
Works
Title | Sources |
---|---|
Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015 | |
Complete sequence and phylogenetic characterisation of Crimean-Congo hemorrhagic fever virus from Afghanistan | |
Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016. | |
Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G | |
Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections | |
Ebola Virus Disease Is Characterized by Poor Activation and Reduced Levels of Circulating CD16+ Monocytes | |
Entwicklung eines EAG-Systems zur Analyse von komplexen Duftstoff-Gemischen | |
Epizootic emergence of Usutu virus in wild and captive birds in Germany | |
Evidence for a decrease in transmission of Ebola virus--Lofa County, Liberia, June 8-November 1, 2014. | |
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea | |
Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency | |
Increase in West Nile virus infections imported to Germany in 2012. | |
Kinetics of Soluble Mediators of the Host Response in Ebola Virus Disease | |
Laboratory findings, compassionate use of favipiravir, and outcome in patients with Ebola virus disease, Guinea, 2015 — a retrospective observational study | |
Male offspring born to mildly ZIKV-infected mice are at risk of developing neurocognitive disorders in adulthood | |
Mayaro virus infection in traveler returning from Amazon Basin, northern Peru | |
Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation | |
Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. | |
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study | |
Rapid outbreak sequencing of Ebola virus in Sierra Leone identifies transmission chains linked to sporadic cases | |
Real-time, portable genome sequencing for Ebola surveillance | |
Severe Yellow fever vaccine-associated disease: a case report and current overview | |
Specific detection of antibodies to different flaviviruses using a new immune complex ELISA. | |
Structure of the Lassa virus nucleoprotein revealed by X-ray crystallography, small-angle X-ray scattering, and electron microscopy | |
Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa | |
Toscana virus infection imported from Elba into Switzerland | |
Two laboratory-confirmed cases of Japanese encephalitis imported to Germany by travelers returning from Southeast Asia | |
Unique human immune signature of Ebola virus disease in Guinea | |
An unusual cause of elevated liver function tests in an elderly female |